DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAA) Operating cash flow
DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$539,187FY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$539,187 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMAA financial trends
DMAA RevenueDMAA Net incomeDMAA Net marginDMAA Gross profitDMAA Gross marginDMAA Operating incomeDMAA Operating marginDMAA Free cash flowDMAA Capital expendituresDMAA Return on equityDMAA Stock buybacksDMAA Dividends paidDMAA Total assetsDMAA Total liabilitiesDMAA Shareholders’ equityDMAA overview →